The Trump administration has cut NIH funding levels and paused new and existing grants from the agency, which totalled $35 billion in 2023. That’s left critical studies of various illnesses and drugs that could help treat them on pause. Doctors, researchers, and scientists who have spent years and often decades studying chronic diseases worry the cuts will have long-lasting consequences for public health and medical innovation.
